Development of an Intranasally- and Intramuscularly-Administrable #Replicon #Vaccine Efficacious Against #H5N1 #Influenza Virus, https://etidiohnew.blogspot.com/2025/04/development-of-intranasally-and.html
Meiji Seika Pharma, has filed a lawsuit against Kazuhiro Haraguchi, a Lower House member from the Constitutional Democratic Party, saying his comments on the firm’s new COVID-19 vaccine greatly damaged its reputation. https://www.japantimes.co.jp/news/2024/12/29/japan/science-health/covid-vaccine-defamation-lawsuit/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #vaccinations #covid19 #meijiseikapharma #replicon #covid19vaccines #covid19injapan #medicine
@murodegrizeco
Meiji Seika Pharma obtained exclusive rights from CSL Seqirus (Australian biotech co.) to distribute #replicon vaccine in #Japan with approval from ultra-cautious Ministry of Health, Labor & Welfare, but had to deal with misinformation re the new technology & is seeking damages from Rep. Kazuhiro Haraguchi for "repeated defamatory remarks"
https://www.asahi.com/ajw/articles/15566602
Haraguchi's Japanese Wikipedia bio shows a complex career but not when he became antivax
https://ja.wikipedia.org/wiki/%E5%8E%9F%E5%8F%A3%E4%B8%80%E5%8D%9A
The new replicon COVID-19 vaccine has sparked extreme anxiety among parts of the Japanese public, but the health ministry and experts say such fears are unwarranted. https://www.japantimes.co.jp/news/2024/10/07/japan/science-health/replicon-vaccine-fears/ #japan #sciencehealth #vaccines #covid19 #meijiseikapharma #replicon #covid19vaccines #covid19injapan
